{"id":"https://openalex.org/W4409037699","doi":"https://doi.org/10.1158/1078-0432.28703775","title":"Table 2 from Intratumoral or Subcutaneous MK-2118, a Noncyclic Dinucleotide STING Agonist, with or without Pembrolizumab, for Advanced or Metastatic Solid Tumors or Lymphomas","display_name":"Table 2 from Intratumoral or Subcutaneous MK-2118, a Noncyclic Dinucleotide STING Agonist, with or without Pembrolizumab, for Advanced or Metastatic Solid Tumors or Lymphomas","publication_year":2025,"publication_date":"2025-04-01","ids":{"openalex":"https://openalex.org/W4409037699","doi":"https://doi.org/10.1158/1078-0432.28703775"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.28703775","doi":"https://doi.org/10.1158/1078-0432.28703775","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.28703775","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.28703775","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063337705","display_name":"Jason J. Luke","orcid":"https://orcid.org/0000-0002-1182-4908","observed_orcids":["https://orcid.org/0000-0002-1182-4908"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jason J. Luke","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1182-4908","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073289880","display_name":"Randy F. Sweis","orcid":"https://orcid.org/0000-0002-0497-9637","observed_orcids":["https://orcid.org/0000-0002-0497-9637"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Randy F. Sweis","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0497-9637","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001020016","display_name":"Joel Randolph Hecht","orcid":"https://orcid.org/0000-0003-2277-4157","observed_orcids":["https://orcid.org/0000-0003-2277-4157"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Randolph Hecht","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2277-4157","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053736790","display_name":"Reva Schneider","orcid":"https://orcid.org/0009-0003-5570-7601","observed_orcids":["https://orcid.org/0009-0003-5570-7601"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Reva Schneider","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0003-5570-7601","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071773606","display_name":"Mark N. Stein","orcid":"https://orcid.org/0000-0002-0853-3640","observed_orcids":["https://orcid.org/0000-0002-0853-3640","https://orcid.org/0000-0002-2573-4911"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark N. Stein","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0853-3640","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078820101","display_name":"Talia Golan","orcid":"https://orcid.org/0000-0001-5939-7012","observed_orcids":["https://orcid.org/0000-0001-5939-7012"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Talia Golan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5939-7012","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068368047","display_name":"Timothy Anthony Yap","orcid":"https://orcid.org/0000-0002-2154-3309","observed_orcids":["https://orcid.org/0000-0002-2154-3309"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Timothy A. Yap","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2154-3309","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063684516","display_name":"Anuradha D. Khilnani","orcid":"https://orcid.org/0000-0001-9116-8113","observed_orcids":["https://orcid.org/0000-0001-9116-8113"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anuradha Khilnani","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9116-8113","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060003869","display_name":"Mo Chao Huang","orcid":"https://orcid.org/0000-0002-8399-7525","observed_orcids":["https://orcid.org/0000-0002-8399-7525"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mo Huang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8399-7525","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076810853","display_name":"Runchen Zhao","orcid":"https://orcid.org/0000-0001-8673-3990","observed_orcids":["https://orcid.org/0000-0001-8673-3990"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Runchen Zhao","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8673-3990","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010460004","display_name":"Thomas Jemielita","orcid":"https://orcid.org/0000-0001-7788-1828","observed_orcids":["https://orcid.org/0000-0001-7788-1828"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas Jemielita","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7788-1828","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5070734531","display_name":"Sandip Pravin Patel","orcid":"https://orcid.org/0000-0002-8387-4840","observed_orcids":["https://orcid.org/0000-0002-8387-4840","https://orcid.org/0000-0002-4954-4944"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sandip Pravin Patel","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8387-4840","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6093999743461609,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6093999743461609,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.34619998931884766,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.021700000390410423,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sting-agonist","display_name":"STING agonist","score":0.953000009059906},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.906000018119812},{"id":"https://openalex.org/keywords/intratumoral-administration","display_name":"intratumoral administration","score":0.6899999976158142},{"id":"https://openalex.org/keywords/subcutaneous-administration","display_name":"subcutaneous administration","score":0.9919999837875366},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.8289999961853027},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.7870000004768372},{"id":"https://openalex.org/keywords/lymphoma","display_name":"lymphoma","score":0.7720000147819519},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-combination-therapy","display_name":"immune checkpoint inhibitor combination","score":0.6970000267028809}],"concepts":[{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.8255947828292847},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.660110354423523},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4751715064048767},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4693117141723633},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.4503933787345886},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.44776564836502075},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4032411575317383},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.33534106612205505},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.17001110315322876},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.08482131361961365}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.28703775","doi":"https://doi.org/10.1158/1078-0432.28703775","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.28703775","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/28703775","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/Table_2_from_Intratumoral_or_Subcutaneous_MK-2118_a_Noncyclic_Dinucleotide_STING_Agonist_with_or_without_Pembrolizumab_for_Advanced_or_Metastatic_Solid_Tumors_or_Lymphomas/28703775","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Dataset"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.28703775","doi":"https://doi.org/10.1158/1078-0432.28703775","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.28703775","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4409037655","https://openalex.org/W4409037870","https://openalex.org/W4409038938","https://openalex.org/W4409038999","https://openalex.org/W4406760715","https://openalex.org/W4409038998","https://openalex.org/W4409048469","https://openalex.org/W4416722881","https://openalex.org/W2898106814","https://openalex.org/W4390495691"],"abstract_inverted_index":{"Summary":[0],"of":[1],"DLTs":[2],"(DLT-evaluable":[3],"population)a.":[4]},"counts_by_year":[],"updated_date":"2026-09-24T07:57:37.273135","created_date":"2025-04-01T00:00:00"}